News & Updates
Showing Endocrinology articles
Showing
Metformin helps reduce ADT-related complications in prostate cancer patients
Metformin seems inadequate in reducing the risk of metabolic syndrome (MS) in patients with prostate cancer receiving androgen deprivation therapy (ADT), results of the PRIME study have shown.
Metformin helps reduce ADT-related complications in prostate cancer patients
29 Oct 2025
Obesity linked to COVID-19 severity in children during pre-Omicron wave
A recent study has found that individuals with obesity had more severe COVID-19 during the ancestral and pre-Omicron waves, but not during the Omicron wave.
Obesity linked to COVID-19 severity in children during pre-Omicron wave
28 Oct 2025
Young-onset diabetes: Novel insights on management
At EmW 2025, Professor Andrea Luk from the Department of Medicine & Therapeutics, the Chinese University of Hong Kong, shared insights and recommendations on management of young-onset diabetes (YoD).
Young-onset diabetes: Novel insights on management
28 Oct 2025
![[Infographics] Expanding roles of semaglutide in CKM syndrome](https://cdn.mspsit.mims.com/images/articles/hk-non-076md00-a37499f5-94bf-481b-b399-4a1163c81066-square.png)
Paliperidone 6-month LAI sustains symptomatic, functional remission in schizophrenia at 3 years
Patients with schizophrenia who either continued on the LAI paliperidone palmitate (PP) 6-monthly for up to 3 years or transitioned from PP 3-monthly treatment have sustained symptomatic and functional remission, as shown in a post hoc analysis of the single-arm, OLE study PSY3016